These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 37469482)
1. A rat model of metabolic syndrome-related heart failure with preserved ejection fraction phenotype: pathological alterations and possible molecular mechanisms. Shi Y; Liu C; Yang C; Qiao W; Liu Y; Liu S; Dong G Front Cardiovasc Med; 2023; 10():1208370. PubMed ID: 37469482 [TBL] [Abstract][Full Text] [Related]
2. Sacubitril/valsartan attenuates myocardial inflammation, hypertrophy, and fibrosis in rats with heart failure with preserved ejection fraction. Shi YJ; Yang CG; Qiao WB; Liu YC; Liu SY; Dong GJ Eur J Pharmacol; 2023 Dec; 961():176170. PubMed ID: 37939991 [TBL] [Abstract][Full Text] [Related]
3. Ling-Gui-Qi-Hua formula alleviates left ventricular myocardial fibrosis in rats with heart failure with preserved ejection fraction by blocking the transforming growth factor-β1 /Smads signaling pathway. Shi Y; Liu C; Xiong S; Yang L; Yang C; Qiao W; Liu Y; Liu S; Liu J; Dong G J Ethnopharmacol; 2023 Dec; 317():116849. PubMed ID: 37385575 [TBL] [Abstract][Full Text] [Related]
4. Effects and mechanism of Compound Qidan Formula on rats with HFpEF induced by hypertension and diabetes mellitus based on Ang Ⅱ/TGF-β1/Smads signaling pathway. Yuan P; Liu J; Xiong S; Yang L; Guan J; Dong G; Shi D J Ethnopharmacol; 2023 Sep; 313():116558. PubMed ID: 37116729 [TBL] [Abstract][Full Text] [Related]
5. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. Paulus WJ; Tschöpe C J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677 [TBL] [Abstract][Full Text] [Related]
6. Telmisartan ameliorates cardiac fibrosis and diastolic function in cardiorenal heart failure with preserved ejection fraction. Chang D; Xu TT; Zhang SJ; Cai Y; Min SD; Zhao Z; Lu CQ; Wang YC; Ju S Exp Biol Med (Maywood); 2021 Dec; 246(23):2511-2521. PubMed ID: 34342551 [TBL] [Abstract][Full Text] [Related]
7. Combining three independent pathological stressors induces a heart failure with preserved ejection fraction phenotype. Li Y; Kubo H; Yu D; Yang Y; Johnson JP; Eaton DM; Berretta RM; Foster M; McKinsey TA; Yu J; Elrod JW; Chen X; Houser SR Am J Physiol Heart Circ Physiol; 2023 Apr; 324(4):H443-H460. PubMed ID: 36763506 [TBL] [Abstract][Full Text] [Related]
8. Clinical Phenotypes of Heart Failure With Preserved Ejection Fraction to Select Preclinical Animal Models. van Ham WB; Kessler EL; Oerlemans MIFJ; Handoko ML; Sluijter JPG; van Veen TAB; den Ruijter HM; de Jager SCA JACC Basic Transl Sci; 2022 Aug; 7(8):844-857. PubMed ID: 36061340 [TBL] [Abstract][Full Text] [Related]
9. Resveratrol Ameliorates Cardiac Remodeling in a Murine Model of Heart Failure With Preserved Ejection Fraction. Zhang L; Chen J; Yan L; He Q; Xie H; Chen M Front Pharmacol; 2021; 12():646240. PubMed ID: 34177571 [No Abstract] [Full Text] [Related]
10. A Preclinical Rat Model of Heart Failure With Preserved Ejection Fraction With Multiple Comorbidities. Hubesch G; Hanthazi A; Acheampong A; Chomette L; Lasolle H; Hupkens E; Jespers P; Vegh G; Wembonyama CWM; Verhoeven C; Dewachter C; Vachiery JL; Entee KM; Dewachter L Front Cardiovasc Med; 2021; 8():809885. PubMed ID: 35097026 [TBL] [Abstract][Full Text] [Related]
11. Qishen granule attenuates cardiac fibrosis by regulating TGF-β /Smad3 and GSK-3β pathway. Zeng Z; Wang Q; Yang X; Ren Y; Jiao S; Zhu Q; Guo D; Xia K; Wang Y; Li C; Wang W Phytomedicine; 2019 Sep; 62():152949. PubMed ID: 31102891 [TBL] [Abstract][Full Text] [Related]
12. Cell therapy attenuates endothelial dysfunction in hypertensive rats with heart failure and preserved ejection fraction. de Couto G; Mesquita T; Wu X; Rajewski A; Huang F; Akhmerov A; Na N; Wu D; Wang Y; Li L; Tran M; Kilfoil P; Cingolani E; Marbán E Am J Physiol Heart Circ Physiol; 2022 Nov; 323(5):H892-H903. PubMed ID: 36083797 [TBL] [Abstract][Full Text] [Related]
13. Cellular mechanisms of metabolic syndrome-related atrial decompensation in a rat model of HFpEF. Hohendanner F; Bode D; Primessnig U; Guthof T; Doerr R; Jeuthe S; Reimers S; Zhang K; Bach D; Wakula P; Pieske BM; Heinzel FR J Mol Cell Cardiol; 2018 Feb; 115():10-19. PubMed ID: 29289652 [TBL] [Abstract][Full Text] [Related]
14. Pressure Overload Activates DNA-Damage Response in Cardiac Stromal Cells: A Novel Mechanism Behind Heart Failure With Preserved Ejection Fraction? Stadiotti I; Santoro R; Scopece A; Pirola S; Guarino A; Polvani G; Maione AS; Ascione F; Li Q; Delia D; Foiani M; Pompilio G; Sommariva E Front Cardiovasc Med; 2022; 9():878268. PubMed ID: 35811699 [TBL] [Abstract][Full Text] [Related]
15. Cardiosphere-derived cells reverse heart failure with preserved ejection fraction (HFpEF) in rats by decreasing fibrosis and inflammation. Gallet R; de Couto G; Simsolo E; Valle J; Sun B; Liu W; Tseliou E; Zile MR; Marbán E JACC Basic Transl Sci; 2016; 1(1-2):14-28. PubMed ID: 27104217 [TBL] [Abstract][Full Text] [Related]